Observational analysis of 12 years-experience with OnabotulinumtoxinA in the treatment of chronic migraine treated in a tertiary headache center. Headache Med [Internet]. 2023 Dec. 20 [cited 2026 Jan. 22];14(Supplement):131. Available from: https://headachemedicine.com.br/hm/article/view/992